Curia

Ocular Therapeutix, located in Bedford, MA, is focused on transforming the treatment of retinal diseases, which significantly impact millions of Americans and often lead to blindness. Their ongoing clinical innovations, including the investigational therapy AXPAXLI (OTX-TKI), aim to reduce the treatment burden associated with retinal conditions like wet Age-Related Macular Degeneration. With a team that boasts extensive expertise and a strong track record in retinal disease management, Ocular Therapeutix aspires to improve long-term outcomes for patients by minimizing the need for frequent treatments. Their pipeline reflects a commitment to redefining patient care through advanced therapies and clinical trials. Generated from the website

Endo Pharmaceuticals Solutions Inc is a pharmaceutical company based in Lexington, MA. The company focuses on developing and providing innovative solutions in the field of healthcare and pharmaceuticals. Endo Pharmaceuticals Solutions Inc is committed to advancing medical treatments and improving patient outcomes through its research and development efforts. The company strives to make a positive impact on the healthcare industry through its products and services. Generated from their business information

Shire Specialty Pharmaceuticals is a division of Shire, which offers products under the VYVANSE, DAYTRANA, ADDERALL, FOSRENOL, AGRYLIN, ELAPRASE and PENTASA brand names for the treatment attention deficit hyperactivity disorder. The division sells its products to several pharmaceutical wholesale distributors and pharmacies in the United States and Europe. Founded in 1994, Shire is one of the leading specialty biopharmaceutical companies that focuses on meeting the needs of specialist physicians in Pennsylvania. The parent company has a staff of more than 1,600 employees. Shire s subsidiaries include Shire Human Genetic Therapies UK Limited, Shire Human Genetic Therapies Securities Corporation, Shire Investments & Finance (U.K.) Company, Shire Pharmaceutical Contracts Limited and Shire Intellectual Property 2 SRL.